Clinical Trial News and Research

RSS

Low-calorie 'fasting-mimicking' diet has potential to treat people with IBD

What if a special diet could reduce inflammation and repair your gut? USC researchers provided evidence that a low-calorie "fasting-mimicking" diet has the potential to do just that.

6 Mar 2019

Changing drugs, deprescribing do not lower severity and duration of delirium in ICU patients

The results of two new Regenstrief Institute trials published in the Journal of the American Geriatrics Society underscore and confirm the need to look to options other than medication to lower the duration or severity of delirium in intensive care unit patients.

6 Mar 2019

New therapeutic approach for patients with pancreatic cancer

One-year survival is low among patients diagnosed with pancreatic cancer. Researchers from Huntsman Cancer Institute (HCI) at the University of Utah have now come up with a potential new therapy for pancreatic cancer patients.

5 Mar 2019

Study examines effect of herbal medicine product on bedwetting in children

A new clinical trial investigating whether an herbal medicine product can benefit school-age children experiencing bedwetting is being led by a collaboration between researchers from the Australian Research Centre in Complementary and Integrative Medicine at the University of Technology Sydney and the Office of Research at Endeavour College of Natural Health.

5 Mar 2019

Daily consumption of nutritional supplements does not prevent depression

MooDFOOD, the largest randomized clinical trial to study the effects of nutritional strategies on the prevention of major depressive disorder concludes that daily intake of nutritional supplements cannot prevent depression.

5 Mar 2019

Radiation after surgery in children with ependymoma nearly triples survival rate

Radiation immediately following surgery in children with ependymoma, the third most common pediatric brain tumor, can nearly triple survival.

5 Mar 2019

New combinational drug therapy may effectively combat pancreatic cancer

Even among cancers, pancreatic cancer is an especially sinister form of disease. The one-year survival rate is extremely low, and treatment progress has lagged behind that of many other malignancies.

5 Mar 2019

New therapeutic approach offers promise for patients with pancreatic cancer

Lustgarten Foundation and Stand Up To Cancer, strategic partners in the Pancreatic Cancer Collective, offer comments on research published today in the journal Nature Medicine which describes a new therapeutic approach with promise for patients with pancreatic cancer.

5 Mar 2019

Mid-Atlantic researchers receive grant to test VibeForward device for Parkinson's patients

A Mid-Atlantic research team with roots at the University of Delaware has received a $440,000 grant from The Michael J. Fox Foundation for Parkinson's Research to test a device, called VibeForward, that uses vibration therapy to reduce symptoms of freezing of gait in patients with Parkinson's disease.

5 Mar 2019

GARDP and Penta join forces to deal with drug-resistant infections in children

The Global Antibiotic Research & Development Partnership and Penta, the pediatric infectious diseases research network, have joined forces to tackle drug-resistant infections in children.

5 Mar 2019

Research opens door to promising new treatment strategy for deadly brain tumor in children

A study published in Nature Communications found that an inhibitor of an enzyme called ACVR1 slows tumor growth and increases survival in an animal model of diffuse intrinsic pontine glioma - the most deadly brain tumor in children.

4 Mar 2019

New multi-year affiliation announced to establish global center for rare diseases

The University of Oxford and University Hospitals in Cleveland, Ohio, today announced a multi-year affiliation to establish a global center for rare diseases.

1 Mar 2019

New mobile skin bioprinting system to treat large wounds or burns

Imagine a day when a bioprinter filled with a patient's own cells can be wheeled right to the bedside to treat large wounds or burns by printing skin, layer by layer, to begin the healing process. That day is not far off.

28 Feb 2019

Personalized therapy for aggressive brain cancer shows potential

Advances in genetics and genomics have taught us that every single tumor is different, and yet most standard therapies treat them all in the same way, limiting the effectiveness of treatments offered to many cancer patients.

28 Feb 2019

Newly discovered drug targets could pave way for esophageal cancer therapeutics

Blocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma, the most common esophageal malignancy in the United States, according to new research out of Case Western Reserve University School of Medicine.

28 Feb 2019

C-Path and FARA announce launch of Friedreich's Ataxia Integrated Clinical Database

Critical Path Institute's Data Collaboration Center and the Friedreich's Ataxia Research Alliance today announced the launch of the Friedreich's Ataxia Integrated Clinical Database.

28 Feb 2019

Pioneering trial offers hope for patients with Parkinson’s disease

In a pioneering new clinical trial, researchers have succeeded in delivering a cell-restoring drug directly to the brains of patients with Parkinson’s disease.

27 Feb 2019

Killer T cells may explain inability of immune cells to destroy cancer tumors

Scientists at the University of Virginia School of Medicine have discovered a defect in immune cells known as "killer T cells" that explains their inability to destroy cancer tumors. The researchers believe that repairing this defect could make the cells much better cancer killers.

26 Feb 2019

Penn researchers cure nine HCV patients following heart transplants from infected donors

Nine patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving heart transplants from deceased donors who were infected with the disease, according to a study published in the American Journal of Transplantation.

25 Feb 2019

New analysis highlights increasing focus of early-stage clinical trials on rare cancers

The proportion of early-stage drug trials tackling the biggest cancer killers has declined sharply since the early 1990s as less common tumor types receive increasing attention, according to new research to be presented during the International Congress on Targeted Anticancer Therapies 2019, taking place from today to 27 February in Paris, France.

25 Feb 2019

Clinical Trial News and Research

Low-calorie 'fasting-mimicking' diet has potential to treat people with IBD

Changing drugs, deprescribing do not lower severity and duration of delirium in ICU patients

New therapeutic approach for patients with pancreatic cancer

Study examines effect of herbal medicine product on bedwetting in children

Daily consumption of nutritional supplements does not prevent depression

Radiation after surgery in children with ependymoma nearly triples survival rate

New combinational drug therapy may effectively combat pancreatic cancer

New therapeutic approach offers promise for patients with pancreatic cancer

Mid-Atlantic researchers receive grant to test VibeForward device for Parkinson's patients

GARDP and Penta join forces to deal with drug-resistant infections in children

Research opens door to promising new treatment strategy for deadly brain tumor in children

New multi-year affiliation announced to establish global center for rare diseases

New mobile skin bioprinting system to treat large wounds or burns

Personalized therapy for aggressive brain cancer shows potential

Newly discovered drug targets could pave way for esophageal cancer therapeutics

C-Path and FARA announce launch of Friedreich's Ataxia Integrated Clinical Database

Pioneering trial offers hope for patients with Parkinson’s disease

Killer T cells may explain inability of immune cells to destroy cancer tumors

Penn researchers cure nine HCV patients following heart transplants from infected donors

New analysis highlights increasing focus of early-stage clinical trials on rare cancers

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer